PBIGF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Paradigm Biopharmaceuticals (PBIGF) Ownership - Who owns Paradigm Biopharmaceuticals?

Paradigm Biopharmaceuticals Ltd is a late-stage clinical development company engaged in the research and development of therapeutic products for human use in Australia... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

500 Collins Street

Phone

+61 396295566

Employees

Web

https://www.paradigmbiopharma.com

Details

Group

Domestic Stock Funds

Fundamentals

PBIGF

Capitalization

71.6M

P/E Ratio

N/A

Risk (Beta)

0.39

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.00%

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

2.41

Cash Flow

N/A

Earnings

-0.05

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-15.46M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-38.85

Shares Held By Institutions

10.3M

Shares Outstanding - Current

389M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

-1

Gain YTD

-51.150

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology